PRESS RELEASE
Sep 26, 2023
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje® in Diabetic Foot Ulcers
Sep 19, 2023
BioStem Technologies Initiates Nationwide Launch of AmnioWrap2™ with Venture Medical
Sep 18, 2023
BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
Sep 14, 2023
NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
Sep 11, 2023
NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
Sep 06, 2023
BioStem Awarded a Spot on ECAT, DAPA, and FSS Contract Vehicles Through SDVOSB, Lovell
Mar 23, 2023
BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products
Mar 07, 2023
BioStem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc.
Feb 14, 2023
BioStem Technologies Enters Into a Share Exchange Agreement
Feb 01, 2023
BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing